TFA Therapeutics (RAJAF) Debt Ratio (2020 - 2025)

TFA Therapeutics has reported Debt Ratio for 6 years, with the latest figure at 0.96 in Q4 2025.

• On a quarterly basis, Debt Ratio rose 2.33% year-over-year to 0.96 in Q4 2025; TTM through Dec 2025 was 0.96, a 2.33% increase from a year earlier, with the FY2025 full-year figure at 0.96, up 2.33% from the prior year.
• Debt Ratio was 0.96 for Q4 2025 at TFA Therapeutics, up from 0.94 in the prior quarter.
• The five-year high for Debt Ratio was 0.96 in Q4 2025, with the low at 0.23 in Q3 2023.
• Average Debt Ratio over 5 years is 0.72, with a median of 0.92 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio plunged 62.99% in 2022, then jumped 157.57% in 2023.
• Over 5 years, Debt Ratio stood at 0.95 in 2021, then slumped by 62.99% to 0.35 in 2022, then jumped by 157.57% to 0.91 in 2023, then advanced by 3.65% to 0.94 in 2024, then increased by 2.33% to 0.96 in 2025.
• The last three Debt Ratio figures came in at 0.96 (Q4 2025), 0.94 (Q4 2024), and 0.91 (Q4 2023), per Business Quant data.